Wednesday, January 24, 2018 7:11:24 PM
Tampa, FL -- January 16, 2018 -- InvestorsHub NewsWire -- PPJ Healthcare Enterprises Inc. (OTC Pink: PPJE) announced today that it is finally making its steps into the Cannabis Market as a Cannabis Stock as it had undertaken its plan in the making and distributing medical marijuana edibles in a massive scale (See Press Release Nov 16, 2016). The Company had been actively seeking opportunities and license for to Cultivate, Cooperative, Dispense and all the works. The Company filed its initial request for a Medical Cannabis License in late 2014 with a California city. The Company has been in the que for its turn, it finally is a reality. We have been approved to file our Application for the following license: Medical Cannabis cooperative or collective, cultivation, manufacturing, dispensary and testing facilities. Please see attached link for details:
https://www.scribd.com/document/361995105/Cannabis-License-Application-Slot-Opened-for-Ppje
http://www.treasurer.ca.gov/cbwg/resources/reports/110717-cannabis-report.pdf
The Company is now seeking experienced partners/investors to lead this sector of business and help the Company towards the Development of Medical Cannabis products. Interested parties, please contact Ms. Basu at the Company's main phone or email address. "We have committed to Company's plans to expand our business and work with partners to deliver highest quality food and cannabis medicine in future." said Chandana Basu, PPJE CEO.
As always, PPJE management advises shareholders, company followers and prospective investors to contact their financial advisors if they have questions or concerns about their individual accounts and investment choices. Regarding other news and events, the company reminds its followers to monitor OTC Markets filings tab for further newsworthy events and corporate updates, which will follow as they happen (http://www.ppjenterprise.com).
Go $PPJE
FI$HING FOR THE NEXT TROPHY
$UPERMAN OPINIONS MAY CHANGE WITHOUT NOTICE
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM